Home Drug Codes Q Codes Q0247 · Sotrovimab Injection
Updated July 1st, 2026

Sotrovimab Injection Q Code: Q0247

Injection, sotrovimab, 500 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, sotrovimab, 500 mg
HCPCS Added Date May 26, 2021
Manufacturer GSK
Generic Status HCPCS Discontinued

About Sotrovimab Injection

Sotrovimab Injection is a medication aligned to the HCPCS Q Code: Q0247 for billing, pricing, and reimbursement purposes in the United States. It is an Anti-HIV drug manufactured by GSK.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to Q0247. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Sotrovimab Injection CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Sotrovimab Injection (Q0247) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q0247. Wastage billing guide →

Sotrovimab Injection Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Mild-to-moderate COVID-19 in adults and pediatric patients (≥12 years, ≥40 kg) at high risk for progression to severe disease

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Sotrovimab Injection billing and coding guide?
We have not yet identified a manufacturer source of Sotrovimab Injection billing and coding information.
Are there any available Sotrovimab Injection patient assistance programs?
Our team did not identify a source for Sotrovimab Injection patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Sotrovimab Injection prescribing information?
Sotrovimab Injection prescribing information can be found at the link below: Visit Here →
Where can I find Sotrovimab Injection side effect information?
Information regarding Sotrovimab Injection's side effects can be found at MedlinePlus Visit Here →
Does billing Sotrovimab Injection require JZ/JW wastage modifiers?
CMS does not include Sotrovimab Injection (Q0247) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing Q0247. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.